|
|
|||||||
Langerhans Cell Histiocytosis |
1 Takasago-seibu Hospital, Takasago
2 National Center for Child Health and Development, Tokyo
3 Hokkaido University School of Medicine, Sapporo
4 Osaka General Medical Center, Osaka
5 Kishiwada City Hospital, Kishiwada
6 Narita Red Cross Hospital, Narita
7 Sasebo City General Hospital, Sasebo
8 Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima
9 Toyooka Hospital, Toyooka
10 Shinshu University School of Medicine, Matsumoto and
11 Kyoto Prefectural University of Medicine, Kyoto, Japan
Correspondence: Shinsaku Imashuku, MD, Division of Pediatrics, Takasago-seibu Hospital, 1-10-41 Nakasuji, Takasago, Hyogo Prefecture, Japan 676-0812. E-mail: shinim95{at}mbox.kyoto-inet.or.jp
Clinical features, brain magnetic resonance imaging findings and EDSS scores of 11 patients with neurodegenerative central nervous system Langerhans cell histiocytosis were analyzed in Japan. All patients initially had multi-system-type Langerhans cell histiocytosis; 8 at 1–2 years of age and 3 at a later age. Neurodegenerative central nervous system largermans cell histiocytosis disease developed after a median time interval of 3.9 years from initial diagnosis. With a median follow-up of 4.5 years, 6 patients showed progression of disease with an EDSS score >3. This study demonstrates the importance of early detection of neurodegenerative central nervous system Langerhans cell histiocytosis by brain magnetic resonance imaging, particularly in the follow-up of patients who developed multi-system-type Langerhans cell histiocytosis in early infancy.
Key words: Langerhans cell histiocytosis, late sequelae, neurodegenerative central nervous system disease.
| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |